Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(TSX:BCT)

4.400 -0.150 (-3.30%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,525
Open 4.620
Bid (Size) 4.350 (1)
Ask (Size) 4.440 (49)
Prev. Close 4.550
Today's Range 4.350 - 4.620
52wk Range 0.5100 - 13.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering
Via Investor Brand Network
BioMedNewsBreaks — BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing of $3.05M Public Offering
Via Investor Brand Network

Performance

YTD
+436.6%
+436.6%
1 Month
-19.9%
-19.9%
3 Month
-23.7%
-23.7%
6 Month
+353.6%
+353.6%
1 Year
+42.9%
+42.9%

More News

Read More
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
Via FinancialNewsMedia
Exposures Product Safety
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Via NewMediaWire
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Via TheNewswire.com
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Via NewMediaWire
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
Via FinancialNewsMedia
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via News Direct
Topics Death
Exposures Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via TheNewswire.com
Topics Death
Exposures Death
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Via TheNewswire.com
Topics Stocks
Exposures Product Safety US Equities
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Via News Direct
Exposures Product Safety
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
From ImmunoPrecise Antibodies
Via Business Wire

Frequently Asked Questions

Is BCT publicly traded?
Yes, BCT is publicly traded.
What exchange does BCT trade on?
BCT trades on the Toronto Stock Exchange
What is the ticker symbol for BCT?
The ticker symbol for BCT is BCT on the Toronto Stock Exchange
What is the current price of BCT?
The current price of BCT is 4.400
When was BCT last traded?
The last trade of BCT was at 05/08/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.